Reported Pericardial Toxicities Associated with Acute Myelogenous Leukemia Treatments: A Pharmacovigilance Analysis of the FDA Adverse Reporting Database

This publication has 16 references indexed in Scilit:

• Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System
  European Heart Journal - Cardiovascular Pharmacotherapy, 2018
• Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2
  JAMA Oncology, 2018
• Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
  Current Hematologic Malignancy Reports, 2017
• Targeting BCL2 With BH3 Mimetics: Basic Science and Clinical Application of Venetoclax in Chronic Lymphocytic Leukemia and Related B Cell Malignancies
  Clinical Pharmacology & Therapeutics, 2016
• Mechanisms of Action of Fludarabine Nucleoside Against Human Raji Lymphoma Cells
  Nucleosides, Nucleotides & Nucleic Acids, 2014
• THE DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: EXPERIENCE OF THE PETHEMA GROUP AND REVIEW OF THE LITERATURE.
  Mediterranean Journal of Hematology and Infectious Diseases, 2011
• Large pericardial effusion as a complication in adults undergoing SCT
  Bone Marrow Transplantation, 2010
• Beyond hairy cell: the activity of cladribine in other hematologic malignancies
  Blood, 2010
• Upregulation of the Bcl-2 family of proteins in end stage heart failure
  JACC, 2000
• Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia.
  Journal of Clinical Oncology, 1995